Navigation Links
Ophthalmology in Medical Technology

Tiny Cup Attached to Eye Improves Drug Delivery For Retinal Diseases

... Los Angeles. Dr. Murphree is also Professor of ophthalmology and Pediatrics at the Keck School of Medicine of ... at the Association for Research in Vision and ophthalmology (ARVO) Summer Eye Research Conference on ... outpatient services. It is the largest pediatric ophthalmology program in the nation with multiple subspecialty ...

ESBATech's Antibody Fragment Enters Phase Ib/IIa in Ophthalmology

... of this study and head of the Department of ophthalmology at the Kantonsspital in Lucerne, Switzerland, ... is the most advanced topical antibody fragment in ophthalmology and this study will provide important information ... However, the spectrum of potential indications in ophthalmology lies way beyond classical inflammatory diseases. ...

Durezol(TM) in the Treatment of Uveitis and Ganciclovir in the Treatment of Herpetic Keratitis: Studies of Treatments for Leading Causes of Blindness to Be Presented

... eye diseases will be presented at upcoming ophthalmology meetings: At the American Uveitis Society's ... presented in a poster at the American Academy of ophthalmology (AAO) Meeting (November 8-11, Atlanta). The ... of the Association for Research and Vision in ophthalmology (ARVO), the International Society of ...

Gene Therapy Improves Vision in Patients with Congenital Retinal Disease

... his wife, Jean Bennett, M.D., Ph.D., Professor of ophthalmology at Penn and Senior Investigator at the F.M. Kirby ... to date were identified at the Department of ophthalmology at the Second University of Naples, ... Scheie Eye Institute is the Department of ophthalmology at the University of Pennsylvania. Its ...

Research Highlights Potential Benefits of Telemedicine in Treating Eye Disease

... Ingrid Zimmer-Galler, MD, assistant professor of ophthalmology at the Wilmer Eye Institute at the Johns Hopkins ... said Michael Chiang, MD, assistant professor of ophthalmology and biomedical informatics at the Columbia ... in the future." About the American Academy of ophthalmology The American Academy ...

Improved Cornea Surgery Technique Provides Enhanced Transplant Success

... Researcher at American Academy of ophthalmology Annual Meeting Describes Advance in ... Busin, MD, department head and professor of ophthalmology at the Villa Serena Hospital, Forli, Italy, ... to DSAEK." About the American Academy of ophthalmology AAO is the world's largest association of eye ...

Ellex 2RT Study Demonstrates Clinical Efficacy in Treatment of Diabetic Macular Edema

... of the annual meeting of the American Academy of ophthalmology (AAO). "The first phase clinical outcomes have ... Ph.D., FRCPath, who is Frost Professor of ophthalmology at the Rayne Institute and Head of the Academic Department of ophthalmology at King's College, University of London. The ...

Paloma Pharmaceuticals Presents at the Association for Research in Vision and Ophthalmology 2009 Meeting

... today at the annual meeting of the Association for Research in Vision and ophthalmology 2009 (ARVO 2009), This study, presented by Geoffrey P. Lewis, Ph.D. (along ... , CA. has been accepted for publication in the journal Investigative ophthalmology and Visual Science. Work from this study indicates that ...

ARVO, AOS: Large Study of Lacrisert(R) Dry Eye Insert;

... the 2009 Annual Meeting of the Association for Research in Vision and ophthalmology (ARVO), May 3-7, Ft. Lauderdale, FL, and later in the month at the 145th ... of data to mine over time. Association for Research in Vision and ophthalmology (ARVO) Bruce H. Koffler, M.D., will present data from the study in a ...

Tufts Medical Center Researchers Create a New Predictive Model for Age-related Macular Degeneration (AMD)

... ages. The study, led by Johanna M. Seddon, MD, ScM, Professor of ophthalmology at Tufts University School of Medicine and Director of the Ophthalmic ... variables" was published in the May issue of the journal Investigative ophthalmology & Visual Science. Their research also shows that although AMD ...

ExonHit Therapeutics Expands Strategic Collaboration With Allergan

... of the Scope of the Collaboration to Include Antibody Discovery in ophthalmology - Revised Commercial Terms and Payments to ExonHit if ... and other compounds are in pre-clinical testing for indications in pain, ophthalmology or neurodegenerative diseases. Allergan exercised its option to ...

Portrait(R) Plasma - A New Non-Surgical Option for one of the Most Requested Aesthetic Treatment - Aging Eyes

... of Michigan where he graduated with high honors. He completed his ophthalmology residency at the Illinois Eye and Ear Infirmary before taking fellowship ... at the New England Medical Center, and was an Assistant Professor of ophthalmology at Tufts University School of Medicine. Over the next four years he earned ...

TRACON Pharmaceuticals' Small Molecule TRC102 and Antibody TRC105 to be Presented at ASCO 2009

... 2552 About TRACON TRACON Pharmaceuticals is a privately held biotechnology company focused on the development of products for oncology and ophthalmology treatment, including agents that inhibit angiogenesis. TRACON addresses unmet needs in these areas with first-in-class product candidates that will ...

ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the Association for Research in Vision and Ophthalmology (ARVO) 2009 Annual Meeting

... adverse events in a healthy pediatric population from 10-17 years of age. Results were presented at the Association for Research in Vision and ophthalmology (ARVO) 2009 Annual Meeting in Ft. Lauderdale, FL. In the poster presentation titled "Bepotastine Besilate Ophthalmic Solution 1.5% Reduces ...

Alimera Sciences Announces Presentation of Data From the 12-Month Interim Readout of the Human PK Iluvien(TM) Study at ARVO 2009 Annual Meeting

... of Iluvien(TM) (fluocinolone acetonide (FA) intravitreal insert) will be presented today at 2:00 p.m. at the Association for Research in Vision and ophthalmology (ARVO) Annual Meeting in Ft. Lauderdale, FL. The data in the presentation, entitled "Pharmacokinetics and Pharmacodynamics of Iluvien(TM) (FA ...

Sirion Therapeutics Announces Clinical Data Presentations at the 2009 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

... related to the Company's products, pipeline and research will be presented at the 2009 annual meeting of The Association for Research in Vision and ophthalmology (ARVO) in Ft. Lauderdale, FL. (Logo: http://www.newscom.com/cgi-bin/prnh/20080220/CLW064LOGO ) These presentations include data ...

PEAK Surgical Announces Completion of First PRECISE Clinical Study, Receipt of Medical Design Excellence Award for PEAK(R) Surgery System and Achievement of Over 1,000 Surgeries Using PEAK PlasmaBlade(TM)

... discharges and electrode insulation techniques were originally invented at the Hansen Experimental Physics Laboratory and Department of ophthalmology at Stanford University and developed by PEAK Surgical. About PEAK Surgical, Inc. PEAK Surgical, Inc. is a medical device company that has ...

Neuro Kinetics: Research Suggests I-Portal(R) NOTC Data Shows Mild Traumatic Brain Injuries That Other Technologies Miss

... doctors and researchers in universities and government facilities as well as specialists in fields such as audiology, neurology, neuro-otology, ophthalmology and otolaryngology. MEDIA CONTACT: John Buckman Buckman Communications 412 381 2900 jbuckman@buckman.biz ...

Novagali Pharma Presents Results of its Innovative Latanoprost Formulation for Glaucoma

... & development. The company will present further data in May 2009 during the annual meeting of the Association for Research in Vision and ophthalmology (ARVO, Fort-Lauderdale, FL). About Novagali Pharma Novagali Pharma is an ophthalmic pharmaceutical company that develops ...

PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications

... discharges and electrode insulation techniques were originally developed at the Hansen Experimental Physics Laboratory and Department of ophthalmology at Stanford University . About PEAK Surgical, Inc. PEAK Surgical, Inc. is a medical device company that has developed the PEAK(R) ...

Soft Contact Lenses Do Not Lead to 'Myopic Creep' in Children, Study Shows

... a new study shows. Findings from the three-year study, the largest randomized trial of its kind, appear in the November issue of Investigative ophthalmology & Visual Science, the official journal of The Association for Research in Vision and Ophthalmology. According to the multi-site wearing trial ...

Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain

... M.D. of Silverstein Eye Centers. Dr. Silverstein was a principal investigator in the QID study and also serves as a clinical assistant professor of ophthalmology at the University of Missouri-Kansas City School of Medicine and the University of Health Sciences. "Overall, the results from these studies show ...

PEAK Surgical Announces Positive Results From Preclinical Study of PEAK PlasmaBlade(TM) Needle

... discharges and electrode insulation techniques were originally developed at the Hansen Experimental Physics Laboratory and Department of ophthalmology at Stanford University. PEAK Surgical is exploring the applicability of its technology across numerous surgical fields beyond general surgery, ...

Encouraging Gene Therapy Results in Genetic Form of Blindness

... trials report efficacy and safety. LCA can now be redefined as a potentially curable eye disease," said Samuel G. Jacobson MD, PhD, Professor of ophthalmology at the University of Pennsylvania and Principal Investigator of the study. "This is a major source of encouragement to the patients and to all the ...

'Snapshots' of Eyes Could Serve as Early Warning of Diabetes or Diabetic Eye Disease, U-M Researchers Report

... in the retina of patients who might otherwise remain undiagnosed based on clinical examination alone," says Elner, professor, Department of ophthalmology and Visual Sciences at U-M Medical School. Metabolic stress, and therefore disease, can be detected by measuring the intensity of cellular ...

Prism Glasses Expand the View for Patients with Hemianopia

... which is disturbing and confusing. Peli's solution was to keep the central part prism free and place prisms above and below. The Archives of ophthalmology study evaluated the glasses' ability to improve a patient's walking mobility, which includes obstacle avoidance. Forty-three patients were fitted ...

Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration

... physician assessment of the need for re-treatment in accordance with pre-specified criteria. At the 2008 meeting of the Association for Vision and ophthalmology (ARVO), it was reported that, on average, patients on the PRN dosing schedule maintained the gain in visual acuity and decrease in retinal thickness ...

PEAK Surgical Announces Positive Results From Preclinical Study of PEAK PlasmaBlade(TM) for Obstetric and Gynecologic Surgery

... discharges and electrode insulation techniques were originally developed at the Hansen Experimental Physics Laboratory and Department of ophthalmology at Stanford University. Because the radiofrequency is provided in short on-and-off pulses and the blade is insulated, the PlasmaBlade cuts tissue at ...

ESBATech's Lead Antibody Fragment Enters Clinical Development for Ophthalmic Indications

... acts as a natural depot compartment for ESBA105, allowing for highly attractive maintenance dosing regimens. TNFa is a rapidly emerging target in ophthalmology and ESBA105 has the potential to be a significant advancement in anti-inflammatory ophthalmic medicine." Dominik Escher, Ph.D., Chief Executive ...

DSMB Again Supports Continuation of the Phase III Clinical Trial of Medidur(TM) FA for the Treatment of DME

... of the trial. About Alimera Sciences Inc. Alimera Sciences Inc. is singularly focused on the development and commercialization of prescription ophthalmology pharmaceuticals. Founded by an executive team with extensive development and revenue growth expertise, Alimera Sciences' products are focused on ...

ISTA Pharmaceuticals Announces Physician-Sponsored Clinical Study of Xibrom(TM) Combination Therapy with Lucentis(R)

... Presentation is One of Five Posters Scheduled for the 2008 Annual Meeting of the Association for Research in Vision and ophthalmology (ARVO) IRVINE, Calif., Feb. 22 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA ), announced today the acceptance of an ...

New Implantable Lenses Can Reduce the Need for Glasses After Cataract Surgery

... need for eyeglasses. The Aging Eye, a 48-page Special Health Report edited by Laura Fine, M.D., and Jeffrey Heier, M.D., both instructors of ophthalmology at Harvard Medical School, also covers -- glaucoma, cataract, diabetic retinopathy, and other common eye problems -- how diet affects eye health ...

ISTA Pharmaceuticals Presents Results from Two Phase III Clinical Trials of Xibrom(TM) QD (Once-daily) Formulation at the American Academy of Ophthalmology Annual Meeting

... incidence of ocular adverse events. William B. Trattler, M.D. presented the results during the 2007 Annual Meeting of the American Academy of ophthalmology (AAO) being held in New Orleans, Louisiana. ISTA also announced today a second poster presentation at the AAO meeting. This study demonstrated the ...

Sirion Therapeutics Announces Positive Phase III Results for Difluprednate

... protein antagonist in Phase II development for geographic atrophy associated with dry AMD. In addition, Sirion plans to leverage its expertise in ophthalmology and vision research to identify additional candidates in back of the eye diseases, through both internal research efforts and partnering ...

Inspire Announces Presentations at 2007 Association for Research in Vision and Ophthalmology Annual Meeting

... from five abstracts at the 2007 Association for Research in Vision and ophthalmology (ARVO) Annual Meeting to be held May 6-10, 2007 in Ft. Lauderdale, ... 0.05% for dry eye. Inspire is focused on the therapeutic areas of ophthalmology and respiratory/allergy, and is developing products for dry eye, cystic ...

Dr. Gabriel Sosne to Present New TB4 Data at 2007 ARVO Meeting

... will be speaking at the 2007 Association for Research in Vision and ophthalmology (ARVO) meeting in Ft. Lauderdale, Florida on May 9th to discuss TB4's ... skin and heart, among others," said Dr. Sosne, Assistant Professor of ophthalmology at Wayne State University and the Kresge Eye Institute in Detroit, ...

Sirion Therapeutics Announces Clinical Data to be Presented at the 2007 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

... ST-601 (difluprednate) and ST-602 (fenretinide), will be presented at the 2007 annual meeting of The Association for Research in Vision and ophthalmology (ARVO) in Ft. Lauderdale, FL. In addition to these presentations, the company will be hosting a reception for ARVO attendees. ST-601 ...

Isotechnika's Lead Drug, ISA247, To Be Highlighted at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

... to as LX211 by our partner Lux Biosciences, has been selected as the subject of two presentations at the Association for Research in Vision and ophthalmology (ARVO) annual meeting, being held May 6-10 in Fort Lauderdale, Florida. The first, an oral presentation being given on May 5 during a satellite ...

OXiGENE Announces a Poster Presentation Highlighting Results from its Study of ZYBRETSTAT CA4P in Myopic Macular Degeneration (Study MMD-213) at the 47th Annual Meeting of the Association of Research in Vision and Ophthalmology

... (CA4P) clinical trial in myopic macular degeneration (MMD) was presented at the 47th Annual Meeting of the Association of Research in Vision and ophthalmology (ARVO) in Fort Lauderdale, FL. The abstract may be viewed at www.arvo.org. The following are the poster session details: -0- Poster No.: ...
Other Contents
(Date:9/30/2014)... at the University of California, San Diego, have completed ... using a method that uses the pixels in an ... known as mesh-free simulation. , The researchers, led by ... at the Jacobs School of Engineering at UC San ... method at the CompIMAGE,14 conference in Pittsburgh this month. ...
(Date:9/30/2014)... most comprehensive assessment conducted by the Ocean Health ... of 100 in overall health. In addition, for ... and the 15 ocean regions beyond national jurisdiction ... a healthy climate, safeguarding biodiversity and providing sustainable ... of the index, a partnership led by scientists ...
(Date:9/30/2014)... captured the popular attention of both children and aquarium ... sold as dehydrated eggs, these tiny brine shrimp readily ... tank of salt water. , Physicists, though, are ... shrimp vertically migrate in large groups in response to ... night and retreating deeper during the day. , Two ...
Breaking Biology News(10 mins):First comprehensive meshfree numerical simulation of skeletal muscle tissue achieved 2Rating the planet's oceans 2Rating the planet's oceans 3Laser-guided sea monkeys show how zooplankton migrations may affect global ocean currents 2
(Date:9/30/2014)... Integrated Medicine Alliance , Monmouth ... new medical specialty practice through a unique partnership with ... be located within the company’s Shrewsbury location and will ... Tawfik of American Heart Center, P.C., a highly regarded ... offer Integrated Medicine Alliance patients top notch cardiovascular care ...
(Date:9/30/2014)... 30, 2014(BRONX, NY)Medications are the leading cause of allergy-related ... of death certificates from 1999 to 2010, conducted by ... Albert Einstein College of Medicine of Yeshiva University ... Journal of Allergy and Clinical Immunology , also found ... particularly high among older people and African-Americans and that ...
(Date:9/30/2014)... 2014 EverStryke , the permanent match ... SurvivalLife.com along with a free book and class all about ... Michaels, prompting an investigative review. , “Joe Marshall of ... survival and preparation niche, and this product is an excellent ... and survival products that Joe offers on his website to ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 The ... option to help diabetics curb their sweet tooth, but ... Nature this September, suggests that zero-calorie sweeteners may ... 2 diabetes. , The Weizmann Institute of Science ... fed artificial sweeteners to mice, the mice developed glucose ...
(Date:9/30/2014)... 30, 2014 Hospice & Palliative ... “In Celebration” gala, honoring three outstanding individuals for ... striving to provide extraordinary and dignified comfort, care ... serious or life-limiting illness. , The event was ... NY and recognized William (Bill) J. McGuinness, Director ...
Breaking Medicine News(10 mins):Health News:Integrated Medicine Alliance Announces New Cardiology Practice 2Health News:Comprehensive Study of allergic deaths in US finds medications are main culprit 2Health News:EverStryke: Review Exposes Joe Marshall’s Permanent Match Survival Product 2Health News:Artificial Sweeteners May be Linked to Greater Diabetes Risk 2Health News:Hospice & Palliative Care of Westchester Honors Outstanding Individuals at Annual ‘In Celebration’ Gala 2
Other TagsOther Tags